Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2020-01-22
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

Descovy approved for PrEP usage
by Matt Simonette
2019-10-04

facebook twitter google +1 reddit email


Pharmaceutical giant Gilead Sciences announced Oct. 3 that it had received FDA approval for its medication Descovy to be used as a pre-exposure prophylaxis ( PrEP ) intervention to reduce the chances of HIV transmission. The new medication, according to the company, would offer fewer potential complications to kidneys or bone density than Truvada, the oral medication that has been used for PrEP for several years.

The approval comes shortly before Truvada is scheduled to become available in a less expensive, generic form. A month's supply of Truvada costs well over $1,500; while many states, cities and health organizations have implemented programs to ease access to the drug, and several insurers cover its use, the cost nevertheless has proven to be a barrier to widespread PrEP adoption. Foster City, California-based Gilead also offered copay assistance for Truvada patients. Descovy is expected to be similarly priced.

"Descovy for PrEP provides a new HIV prevention option that matches Truvada's high efficacy with statistically significant improvements in renal and bone safety, which can be an important consideration as people at risk increasingly use PrEP for longer periods of time," said Daniel O'Day, chairman and CEO of Gilead Sciences in a statement. "This is a reflection of Gilead's continued commitment to addressing the evolving needs of people living with or at risk for HIV and to driving innovation across the HIV care continuum."

The approval also comes at a time when many advocates and stakeholders have been questioning the ethics of pharmaceutical pricing by Gilead and other drug companies. Earlier in 2019, many advocates noted that research and development for Truvada as PrEP was essentially paid for from federal funding, not Gilead, calling into question why the medication was so highly priced, when the company did not have to recover those costs. Activist and writer Mark S. King also recently accused Gilead of "duping" him into writing a Medicare-related editorial that he later determined was ultimately in the service of a company marketing initiative.

King's account of the experience with Gilead is at marksking.com/my-fabulous-disease/gilead-duped-me-into-being-their-mouthpiece-heres-how/ .


facebook twitter google +1 reddit email





Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Gay News

Tenn. Gov. Bill Lee signs anti-gay adoption bill 2020-01-25 - Tennessee Gov. Bill Lee signed a controversial bill that would let adoption agencies deny service to same-sex couples, among others, based on religious ...


Gay News

Center announces new security provider 2020-01-22 - Center on Halsted has finally selected a new security provider, according to a statement released by Center officials the afternoon of Jan. 22. ...


Gay News

Federal court ruling benefits same-sex couples 2020-01-22 - A federal appeals panel of Republican appointees ruled Jan. 17 that the state of Indiana must treat same-sex married couples the same as ...


Gay News

Me Too movement founder at NU Jan. 27 2020-01-22 - Me Too movement founder Tarana Burke will keynote Martin Luther King Jr. Dream Week on Monday, Jan. 27. Burke will speak on the ...


Gay News

Lambda Legal releases report on judicial nominees 2020-01-22 - Lambda Legal released the third edition of its annual report of judicial nominees, showing how the Trump-Pence administration, with the help of Senate ...


Gay News

Planned Parenthood, We Testify release "Ours to Tell" short film 2020-01-21 - New York, NY — Planned Parenthood Federation of America ( PPFA ) and We Testify, an organization dedicated to the leadership and representation ...


Gay News

WORLD Swiss votes, HIV+ pilot, Indonesian raids, Dutch beauty expert 2020-01-21 - On Feb. 9, Switzerland residents will decide on extending the scope of anti-racism legislation to include discrimination based on sexual orientation, according to ...


Gay News

NATIONAL Presidential candidates, HIV news, Seattle LGBTQ bars, Tom of Finland 2020-01-21 - Presidential candidate Tom Steyer was baffled by his own comments he previously made on protecting the health of LGBTQ asylum seekers when asked ...


Gay News

Indiana same-sex parents can list both names on children's birth certificates 2020-01-19 - On Jan. 17—after more than two and a half years—the 7th U.S. Circuit Court of Appeals ruled that married same-sex couples in Indiana ...


Gay News

Children Born Abroad to Married U.S. Same-Sex Parents Are U.S. Citizens 2020-01-17 - ( New York, NY — January 17, 2020 ) Lambda Legal, Immigration Equality and pro bono counsel Morgan Lewis this week urged federal ...


 



Copyright © 2020 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor


 



About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.